US Patent Issued to Iovance Biotherapeutics on Feb. 17 for "Methods and compositions for T-cell coculture potency assays and use with cell therapy products" (Florida, New York, Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,031, issued on Feb. 17, was assigned to Iovance Biotherapeutics Inc. (San Carlos, Calif.).

"Methods and compositions for T-cell coculture potency assays and use with cell therapy products" was invented by Michelle R. Simpson-Abelson (Lithia, Fla.), Matthew J. Frigault (Dorchester, Mass.), Wayne P. Rothbaum (New York) and Michael Weiser (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel processes, compositions, and methods for analyzing or assaying the potency and/or functionality of tumor infiltrating lymphocyte (TIL) products for use in therapy, including human cancer therapy, and analyzing or assaying the po...